We are live on ! Find out more
AXDX

Accelerate Diagnostics

Delisted

AXDX was delisted on the 14th of May, 2025.

123 hedge funds and large institutions have $448M invested in Accelerate Diagnostics in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 9

110% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 21

82% more capital invested

Capital invested by funds: $246M → $448M (+$202M)

12% more funds holding

Funds holding: 110123 (+13)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

34% less call options, than puts

Call options by funds: $5.31M | Put options by funds: $8.09M

Holders
123
Holders Change
+13
Holders Change %
+11.82%
% of All Funds
2.52%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
23
Increased
44
Reduced
21
Closed
9
Calls
$5.31M
Puts
$8.09M
Net Calls
-$2.78M
Net Calls Change
-$1.14M
Name Holding Trade Value Shares
Change
Change in
Stake
CIBC Private Wealth Group
126
CIBC Private Wealth Group
Georgia
-$339K -4,069 Closed
Simplex Trading
127
Simplex Trading
Illinois
-$283K -2,868 Closed
OR
128
Olympiad Research
Connecticut
-$161K -1,928 Closed
First Trust Advisors
129
First Trust Advisors
Illinois
-$117K -1,405 Closed
Victory Capital Management
130
Victory Capital Management
Texas
-$96K -1,141 Closed
AG
131
Aperio Group
California
-$89K -1,073 Closed
Walleye Trading
132
Walleye Trading
New York
-$23K -274 Closed

AXDX Hedge Fund Activity: Q2 2020 in Review

123 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q2 2020, worth a combined $448M — up 82% from $246M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new AXDX positions and 9 closed out — a net gain of 14 holders — while 44 added to existing stakes and 21 trimmed.

The largest buyer was Baird Financial Group, adding an estimated $4.18M. The largest seller was Credit Suisse, cutting an estimated $11.9M.

  • 123 institutional investors held Accelerate Diagnostics (AXDX) as of Q2 2020, up from 110 in Q1 2020.
  • Funds reported $448M of Accelerate Diagnostics stock for Q2 2020, up 82% quarter-over-quarter.
  • 23 funds opened new Accelerate Diagnostics positions in Q2 2020 and 9 closed out, a net change of +14 holders.
  • The largest Accelerate Diagnostics buyer in Q2 2020 was Baird Financial Group, an estimated $4.18M added.
  • The largest Accelerate Diagnostics seller in Q2 2020 was Credit Suisse, an estimated $11.9M sold.

Based on aggregated 13F filings for Q2 2020.